Literature DB >> 90016

Structure and serological specificity of the K13-antigenic polysaccharide (K13 antigen) of urinary tract-infective Escherichia coli.

W F Vann, K Jann.   

Abstract

The primary structure of the K13-antigenic polysaccharide (K13 antigen) of Escherichia coli O6:K13:H1 was elucidated by composition, periodate oxidation, Smith degradation, and methylation analysis. The polysaccharide consists of a repeating sequence of 3-linked ribofuranose and 7-linked 3-deoxymannooctulosonic acid (KDO). About 50% of the KDO residues are O-acetylated at position 4 or 5. Measurement of the optical rotary dispersion indicated that in aqueous solution the K13 polysaccharide assumes a secondary structure in which the carboxyl groups of KDO are engaged. The serological specificity of the K13 polysaccharide is expressed through KDO and its O-acetyl substituent, the ribose unit being antigenically silent. There are two populations of anti-K13 antibodies one directed against the charged region of the KDO and the other against the O-acetyl groups.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 90016      PMCID: PMC414424          DOI: 10.1128/iai.25.1.85-92.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  A sensitive colorimetric method for the estimation of 2-deoxy sugars with the use of the malonaldehyde-thiobarbituric acid reaction.

Authors:  V S WARAVDEKAR; L D SASLAW
Journal:  J Biol Chem       Date:  1959-08       Impact factor: 5.157

2.  THE STRUCTURE AND CHEMISTRY OF COLOMINIC ACID.

Authors:  E J MCGUIRE; S B BINKLEY
Journal:  Biochemistry       Date:  1964-02       Impact factor: 3.162

3.  A RAPID PERMETHYLATION OF GLYCOLIPID, AND POLYSACCHARIDE CATALYZED BY METHYLSULFINYL CARBANION IN DIMETHYL SULFOXIDE.

Authors:  S HAKOMORI
Journal:  J Biochem       Date:  1964-02       Impact factor: 3.387

Review 4.  Serology, chemistry, and genetics of O and K antigens of Escherichia coli.

Authors:  I Orskov; F Orskov; B Jann; K Jann
Journal:  Bacteriol Rev       Date:  1977-09

5.  Experimental hematogenous pyelonephritis due to Escherichia coli in rabbits: the antibody response and its protective capacity.

Authors:  B Kaijser; S Olling
Journal:  J Infect Dis       Date:  1973-07       Impact factor: 5.226

6.  An unusual acidic polysaccharide produced by a rough strain of Escherichia coli.

Authors:  P W Taylor
Journal:  Biochem Biophys Res Commun       Date:  1974-11-06       Impact factor: 3.575

7.  The O8 antigen of Escherichia coli. Structure of the polysaccharide chain.

Authors:  K Reske; K Jann
Journal:  Eur J Biochem       Date:  1972-12-04

8.  A sensitive reagent for detecting 2-deoxysugars and 3-deoxypolyols.

Authors:  P J Anderson
Journal:  J Chromatogr       Date:  1966-01

9.  An Escherichia coli antigen cross-reactive with the capsular polysaccharide of Haemophilus influenzae type b: occurrence among known serotypes, and immunochemical and biologic properties of E. coli antisera toward H. influenzae type b.

Authors:  R Schneerson; M Bradshaw; J K Whisnant; R L Myerowitz; J C Parke; J B Robbins
Journal:  J Immunol       Date:  1972-06       Impact factor: 5.422

10.  Structural elucidation of the 3-deoxy-D-manno-octulosonic acid containing meningococcal 29-e capsular polysaccharide antigen using carbon-13 nuclear magnetic resonance.

Authors:  A K Bhattacharjee; H J Jennings; C P Kenny
Journal:  Biochemistry       Date:  1978-02-21       Impact factor: 3.162

View more
  10 in total

1.  Activation of human neutrophils by mycobacterial phenolic glycolipids.

Authors:  J Fäldt; C Dahlgren; A Karlsson; A M Ahmed; D E Minnikin; M Ridell
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

2.  Expression of the capsular K5 polysaccharide of Escherichia coli: biochemical and electron microscopic analyses of mutants with defects in region 1 of the K5 gene cluster.

Authors:  D Bronner; V Sieberth; C Pazzani; I S Roberts; G J Boulnois; B Jann; K Jann
Journal:  J Bacteriol       Date:  1993-09       Impact factor: 3.490

3.  Purification and characterization of Staphylococcus aureus type 8 capsular polysaccharide.

Authors:  J M Fournier; W F Vann; W W Karakawa
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

4.  Structure of the Escherichia coli K2 capsular antigen, a teichoic acid-like polymer.

Authors:  K Jann; B Jann; M A Schmidt; W F Vann
Journal:  J Bacteriol       Date:  1980-09       Impact factor: 3.490

5.  Monoclonal antibodies to enterobacterial common antigen and to Escherichia coli lipopolysaccharide outer core: demonstration of an antigenic determinant shared by enterobacterial common antigen and E. coli K5 capsular polysaccharide.

Authors:  H Peters; M Jürs; B Jann; K Jann; K N Timmis; D Bitter-Suermann
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

6.  Serological, chemical, and structural analyses of the Escherichia coli cross-reactive capsular polysaccharides K13, K20, and K23.

Authors:  W F Vann; T Soderstrom; W Egan; F P Tsui; R Schneerson; I Orskov; F Orskov
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

7.  Safety and immunogenicity of a group 29E meningococcal capsular polysaccharide vaccine in adults.

Authors:  J M Griffiss; B L Brandt; P L Altieri; G B Pier; S L Berman
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

8.  Neonatal administration of idiotype or antiidiotype primes for protection against Escherichia coli K13 infection in mice.

Authors:  K E Stein; T Söderström
Journal:  J Exp Med       Date:  1984-10-01       Impact factor: 14.307

9.  Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates.

Authors:  R Schneerson; O Barrera; A Sutton; J B Robbins
Journal:  J Exp Med       Date:  1980-08-01       Impact factor: 14.307

10.  Chemical structure and genetic organization of the E. coli O6:K15 capsular polysaccharide.

Authors:  Hugo F Azurmendi; Vamsee Veeramachineni; Stephen Freese; Flora Lichaa; Darón I Freedberg; Willie F Vann
Journal:  Sci Rep       Date:  2020-07-28       Impact factor: 4.996

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.